Statins and Cancer Prevention—Association Does Not Mean Causation
- 4 January 2023
- journal article
- editorial
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 16 (1) , 1-3
Abstract
Statins are widely prescribed medications that inhibit 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG CoA) reductase and therefore reduce cholesterol synthesis. Given the key role of cholesterol in cancer, statins may therefore have anticancer activities. However, clinical studies investigating the association between statin usage and cancer development have been few and inconsistent. A recent study from Maeda-Minami and colleagues found a significant, though modest, decrease in cancer risk among statin users. However, does this finding mean statin usage directly reduces cancer risk or is merely associated with reduced cancer risk? This editorial analyzes Maeda-Minami and colleagues’ study to provide commentary on statin's proposed role in preventing cancer. See related article, p. 37Keywords
This publication has 16 references indexed in Scilit:
- The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysisScientific Reports, 2016
- A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancerBritish Journal of Cancer, 2015
- Dietary patterns and colorectal cancer: results from a Canadian population-based studyNutrition Journal, 2015
- Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trialThe Lancet Oncology, 2015
- 5α-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate CancerJAMA Internal Medicine, 2014
- Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkageBMJ Open, 2012
- Observational Studies Analyzed Like Randomized ExperimentsEpidemiology, 2008
- Anti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer TherapyCurrent Cancer Drug Targets, 2005
- Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trialBritish Journal of Cancer, 2001
- Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach.1999